Answers are grounded in this paper and cite their sources.
Severe xerostomia may impair dissolution and transmucosal absorption of fentanyl sublingual tablets, complicating rescue analgesia in patients with cancer. We report a 77-year-old woman with advanced ovarian cancer, leptomeningeal metastases, severe xerostomia, and a nasogastric tube. During hospitalization, fentanyl sublingual tablets relieved headache. After transfer to a hospice-oriented residential care facility, pain-related vocalization persisted. Despite use of oral moisturizers, a fentanyl sublingual tablet remained intact under the tongue approximately 30 min after administration and was removed. The transdermal fentanyl dose was increased, but additional analgesia was considered necessary. Because no alternative rescue medication was immediately available, a 100-μg fentanyl sublingual tablet was dissolved in warm water and administered through the nasogastric tube as a one-time off-label emergency measure. Vocalization ceased 30 min later, with no apparent respiratory depression, excessive sedation, nausea, vomiting, or tube obstruction. Nasogastric administration of fentanyl sublingual tablets is nonstandard and should not be adopted routinely. The response cannot be attributed definitively to nasogastric fentanyl administration because the developing effect of the increased transdermal dose and symptom fluctuations could not be excluded. Nevertheless, this case may inform rescue-medication and route-of-administration decisions when severe xerostomia compromises sublingual administration and no suitable alternative is immediately available.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: